Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | $0.30 | $0.37 | $0.34 |
| Q2 2026 | 2 | $0.25 | $0.29 | $0.28 |
| Q3 2026 | 1 | -$0.06 | -$0.05 | -$0.06 |
| Q4 2026 | 1 | -$0.09 | -$0.07 | -$0.08 |
| Q1 2027 | 1 | $0.16 | $0.21 | $0.18 |
| Q2 2027 | 1 | $0.16 | $0.21 | $0.18 |
| Q3 2027 | 1 | $0.15 | $0.19 | $0.17 |
| Q4 2027 | 1 | $0.16 | $0.20 | $0.18 |
| Q1 2028 | 1 | $0.33 | $0.41 | $0.36 |
| Q2 2028 | 1 | $0.34 | $0.42 | $0.37 |
| Q3 2028 | 1 | $0.33 | $0.42 | $0.37 |
| Q4 2028 | 1 | $0.34 | $0.43 | $0.38 |
CorMedix Inc last posted its earnings results on Thursday, March 5th, 2026. The company reported $0.61 earnings per share for the quarter, missing analysts' consensus estimates of $0.86 by $0.25. The company had revenue of 128.62 M for the quarter and had revenue of 311.71 M for the year. CorMedix Inc has generated $2 earnings per share over the last year ($2.04 diluted earnings per share) and currently has a price-to-earnings ratio of 3.63. CorMedix Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/05/2026 | Q4 2025 | $0.86 | $0.18 | -0.68 | $127.02 M | $128.62 M |
| 11/12/2025 | Q3 2025 | $0.48 | $1.42 | 0.94 | $86.02 M | $104.28 M |
| 08/07/2025 | Q2 2025 | $0.20 | $0.29 | 0.09 | $35.08 M | $39.74 M |
| 05/06/2025 | Q1 2025 | $0.25 | $0.32 | 0.07 | $36.95 M | $39.08 M |
| 03/25/2025 | Q4 2024 | $0.17 | $0.22 | 0.05 | $27.28 M | $31.21 M |
| 10/30/2024 | Q3 2024 | -$0.10 | -$0.05 | 0.05 | $10.35 M | $11.46 M |
| 08/14/2024 | Q2 2024 | -$0.26 | -$0.25 | 0.01 | $1.67 M | $806.12 K |
| 05/09/2024 | Q1 2024 | -$0.27 | -$0.25 | 0.02 | $3.00 M | $0 |
| 03/12/2024 | Q4 2023 | -$0.21 | -$0.26 | -0.05 | N/A | $0 |
| 11/14/2023 | Q3 2023 | -$0.21 | -$0.17 | 0.04 | N/A | $0 |
| 08/08/2023 | Q2 2023 | -$0.22 | -$0.25 | -0.03 | N/A | $0 |
| 05/15/2023 | Q1 2023 | -$0.20 | $9.78 | 9.98 | N/A | $0 |
| 03/30/2023 | Q4 2022 | -$0.19 | -$0.19 | 0 | N/A | $29.70 K |
| 11/10/2022 | Q3 2022 | -$0.23 | -$0.17 | 0.06 | N/A | $6.82 K |
| 08/11/2022 | Q2 2022 | -$0.20 | -$0.19 | 0.01 | N/A | $21.25 K |
| 05/12/2022 | Q1 2022 | -$0.23 | -$0.18 | 0.05 | N/A | $7.64 K |
| 03/29/2022 | Q4 2021 | -$0.22 | -$0.21 | 0.01 | N/A | $56.40 K |
| 11/09/2021 | Q3 2021 | -$0.18 | -$0.22 | -0.04 | N/A | $38.09 K |
| 08/12/2021 | Q2 2021 | -$0.18 | -$0.12 | 0.06 | N/A | $8.19 K |
| 05/13/2021 | Q1 2021 | -$0.18 | -$0.20 | -0.02 | N/A | $88.26 K |
The conference call for CorMedix Inc's latest earnings report can be listened to online.
The conference call transcript for CorMedix Inc's latest earnings report can be read online.
CorMedix Inc (:CRMD) has a recorded annual revenue of $311.71 M.
CorMedix Inc (:CRMD) has a recorded net income of $163.06 M.CorMedix Inc has generated $2.25 earnings per share over the last four quarters.
CorMedix Inc (:CRMD) has a price-to-earnings ratio of 3.63 and price/earnings-to-growth ratio is 0.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED